by michaelhalassa | Jul 16, 2025 | Cobenfy, Algorithmic psychiatry, Computational psychiatry, Distributed neural systems, Dopamine and psychosis, KarXT, Mental health treatment, Michael Halassa, muscarinic antipsychotic, Schizophrenia treatment, Xanomeline
I had the privilege of attending and in part organizing the inaugural Innovation in Psychosis Therapeutics Summit in Boston (June 9-11, 2025). This intimate gathering brought together scientists, clinicians and biotech leaders who share a common goal: to finally push...
by | Mar 11, 2025 | Cobenfy, Schizophrenia treatment, Trospium, Xanomeline
The Story of Tim: A Turning Point Tim, a young man in his mid-20s, had been struggling with schizophrenia for years. Despite multiple antipsychotic trials, his symptoms remained poorly controlled. He experienced severe side effects—weight gain, sedation, and...
